Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages.
Components of the extracellular matrix (ECM) can regulate leukocyte activation and function at inflammatory sites. Low molecular weight fragments of the ECM glycosaminoglycan hyaluronan (LMW-HA) that accumulate in inflammation, but not the ubiquitous high molecular weight form of HA (HMW-HA), have been shown to induce cytokine and/or chemokine production by alveolar and bone-marrow derived macrophages. To determine the cellular requirements for responsiveness to HA, we compared the effects of HMW-HA and LMW-HA on resident and thioglycollate-elicited murine peritoneal macrophages. We demonstrate that treatment of elicited macrophages with LMW-HA, but not with HMW-HA, stimulated production of the chemokines RANTES and macrophage inflammatory protein-1alpha and -1beta. Further, we demonstrate that LMW-HA induced the production of biologically active IL-12, a proinflammatory cytokine not previously known to be regulated by cell-matrix interactions. The LMW-HA-induced production of IL-12 by elicited macrophages was inhibited by an anti-CD44 mAb that blocks HA binding. In contrast to elicited macrophages, freshly explanted resident peritoneal macrophages did not respond to LMW-HA. However, preculture in vitro before stimulation led to adhesion-dependent priming for LMW-HA-induced cytokine and chemokine production by resident macrophages. These results provide further evidence of the potential importance of CD44/LMW-HA interactions in regulating the immune response at sites of inflammation and demonstrate that the state of differentiation of macrophages may determine their sensitivities to matrix components.
Hodge-Dufour
J
J
Immunology Graduate Group, University of Pennsylvania, Philadelphia 19104, USA.
Noble
P W
PW
Horton
M R
MR
Bao
C
C
Wysoka
M
M
Burdick
M D
MD
Strieter
R M
RM
Trinchieri
G
G
Puré
E
E
D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D002448:Cell Adhesion; D018925:Chemokines / Q000096:biosynthesis* / Q000235:genetics; D005109:Extracellular Matrix / Q000502:physiology; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects*; D018960:Hyaluronan Receptors / Q000276:immunology / Q000502:physiology*; D006820:Hyaluronic Acid / Q000737:chemistry / Q000494:pharmacology*; D007249:Inflammation / Q000503:physiopathology; D007371:Interferon-gamma / Q000494:pharmacology; D018664:Interleukin-12 / Q000096:biosynthesis* / Q000235:genetics; D008262:Macrophage Activation; D017737:Macrophages, Peritoneal / Q000187:drug effects* / Q000378:metabolism; D051379:Mice; D008809:Mice, Inbred C3H; D008970:Molecular Weight; D010537:Peritoneum / Q000166:cytology; D010538:Peritonitis / Q000139:chemically induced / Q000473:pathology; D013864:Thioglycolates / Q000633:toxicity
D000911:Antibodies, Monoclonal; D018925:Chemokines; D018960:Hyaluronan Receptors; D013864:Thioglycolates; D018664:Interleukin-12; D007371:Interferon-gamma; D006820:Hyaluronic Acid